Industry News
Phosphagenics appoints consultant for promoting drug delivery tech
Phosphagenics (ASX:POH) has engaged the services of Dr Steve Meller to assist the company in partnering its TPM (Targeted Penetration Matrix) drug delivery technology with large companies selling into the mass market. [ + ]
Clinical Network Services is Australia's favourite CRO
Clinical Network Services (CNS), an integrated service group focused on clinical product development, has been announced as Australia's favourite CRO for 2015 by ARCS Australia. [ + ]
The search for Australia's next Chief Scientist
The Australian Government has begun the process to select Australia's next Chief Scientist, in preparation for the conclusion of Professor Ian Chubb's tenure at the end of the year. [ + ]
Sea slug census is on this Saturday
Members of the Combined Hunter Underwater Group (CHUG), Southern Cross University's (SCU) National Marine Science Centre and Underwater Volunteers NSW will this Saturday visit Nelson Bay, Port Stephens, to record and identify sea slug diversity. [ + ]
Wanted: The best Queensland women in technology
Women in Technology (WiT) is once again holding its annual awards program, with nominations open from now until 30 June. The technology industry association supports, develops, recognises and promotes the achievements of Queensland women in ICT and life sciences. [ + ]
The role of immune cells in asthma
Researchers from Sydney's Centenary Institute have discovered a pathway that may be vital for our understanding of allergic asthma - the prevalent form of childhood-onset asthma affecting 2 million Australians. [ + ]
Partnership and Early Access Program for Antisense
Melbourne biotech Antisense Therapeutics (ASX:ANP) has announced an Early Access Program (EAP) for its multiple sclerosis (MS) therapy ATL1102 in the European Union, as well as a partnership with a US-based company to develop its growth disorder treatment ATL1103. [ + ]
Orphan designation for Huntington's candidate
Prana Biotechnology has announced that the European Commission has approved orphan designation for its lead drug candidate, PBT2, for the treatment of Huntington's disease. [ + ]
New urine testing method to improve disease detection
Researchers from Clemson University have developed a new urine testing method that is said to reduce costs, achieve faster results, lower the volume of fluid needed and remove the need for invasive blood tests. [ + ]
Quantum tunnelling is an instantaneous process
An international team of scientists studying ultrafast physics has solved a mystery of quantum mechanics, finding that quantum tunnelling is an instantaneous process. [ + ]
Reality does not exist until it is measured
Physicists at The Australian National University (ANU) have performed a famous experiment in quantum theory, created by the late theoretical physicist John Wheeler, which suggests that reality does not exist until it is measured. [ + ]
Birds combat climate change with bigger beaks
Research led by Deakin University has discovered a pattern between increased climatic temperatures and an increase in the size of the beaks of parrot species in southern and eastern Australia, suggesting that the birds have evolved the larger beaks to cope with a changing climate. [ + ]
Smartphones converted into biosensors
Researchers from the ARC Centre for Nanoscale BioPhotonics have reconfigured smartphones as bioanalytical devices that allow for immediate diagnostic testing of arthritis, cystic fibrosis, acute pancreatitis and other clinical diseases. [ + ]
Academy elects new Fellows for 2015
The Australian Academy of Science has announced the election of 21 new Fellows for their outstanding contributions to science and scientific research. [ + ]
New Cochlear CEO appointed
Chris Smith has been announced as the incoming CEO and president of Cochlear Limited (ASX:COH). He will become the company's deputy CEO from 1 July and relocate to Sydney to take up the CEO position as of 1 September. [ + ]